Jounce Therapeutics Stock Filter Stocks by Fundamentals
JNCEDelisted Stock | USD 1.88 0.00 0.00% |
Jounce Therapeutics fundamentals help investors to digest information that contributes to Jounce Therapeutics' financial success or failures. It also enables traders to predict the movement of Jounce Stock. The fundamental analysis module provides a way to measure Jounce Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jounce Therapeutics stock.
Jounce |
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
All Next | Launch Module |
Jounce Fundamentals
Return On Equity | -0.25 | |||
Return On Asset | -0.14 | |||
Profit Margin | (0.62) % | |||
Operating Margin | (0.64) % | |||
Current Valuation | (82.09 M) | |||
Shares Outstanding | 52.64 M | |||
Shares Owned By Insiders | 15.99 % | |||
Shares Owned By Institutions | 85.33 % | |||
Number Of Shares Shorted | 2.02 M | |||
Price To Earning | 10.76 X | |||
Price To Book | 0.27 X | |||
Price To Sales | 7.27 X | |||
Revenue | 82 M | |||
Gross Profit | 27.2 M | |||
EBITDA | (50.16 M) | |||
Net Income | (50.92 M) | |||
Cash And Equivalents | 148.56 M | |||
Cash Per Share | 2.87 X | |||
Total Debt | 11.89 M | |||
Debt To Equity | 0.07 % | |||
Current Ratio | 6.78 X | |||
Book Value Per Share | 3.54 X | |||
Cash Flow From Operations | (28.88 M) | |||
Short Ratio | 0.48 X | |||
Earnings Per Share | (0.96) X | |||
Target Price | 2.0 | |||
Number Of Employees | 141 | |||
Beta | 0.75 | |||
Market Capitalization | 101.59 M | |||
Total Asset | 212.55 M | |||
Retained Earnings | (292.79 M) | |||
Working Capital | 173.66 M | |||
Current Asset | 103.95 M | |||
Current Liabilities | 51.26 M | |||
Z Score | 3.78 | |||
Net Asset | 212.55 M |
About Jounce Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jounce Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jounce Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jounce Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Jounce Stock
If you are still planning to invest in Jounce Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Jounce Therapeutics' history and understand the potential risks before investing.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |